Deadly drug-resistant infections are surging in European hospitals
Strains of Klebsiella pneumoniae have evolved to resist even the newest antibiotics.
A drug-resistant superbug, Klebsiella pneumoniae, is surging in European hospitals, posing a significant threat to patient safety and treatment efficacy. According to the European Centre for Disease Prevention and Control (ECDC), cases of bloodstream infections caused by this treatment-resistant bacterium have increased by 72% between 2019 and 2025, falling short of the target set for a 5% reduction by 2030.
The ECDC warns that several strains of Klebsiella are becoming resistant to nearly all antibiotics, including newer ones, and can cause severe illness and death with a high mortality rate. The ECDC emphasizes the need for stronger infection prevention and control measures in hospitals, such as enhanced hand hygiene, proper use of personal protective equipment, and effective environmental cleaning, as the bacterium can spread easily between patients.
Brief written by urgent.news from Politico EU's own syndicated text. Machine-written — may contain errors; check the original before relying on it.